Medical Technology - Northern Africa

Northern Africa

The Medical Technology market market in Northern Africa is expected to achieve a revenue of US$4.18bn in 2024.
Among the various markets within this market, Medical Devices are projected to be the largest, with a market volume of US$3.52bn in the same year.
Looking ahead, the revenue is anticipated to grow at an annual rate of 6.51% (CAGR 2024-2029), resulting in a market volume of US$5.73bn by 2029.
It is worth noting that in a global context, the United States is expected to generate the highest revenue, reaching US$211.10bn in 2024.
In Northern Africa, the medical technology market is experiencing a surge in demand for telemedicine solutions to improve access to healthcare in remote areas.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in Northern Africa is experiencing significant growth and development in recent years. Customer preferences in the Medical Technology market in Northern Africa are driven by the increasing demand for advanced healthcare solutions and the need to improve healthcare outcomes. Patients and healthcare professionals are increasingly seeking innovative medical technologies that can enhance diagnosis, treatment, and patient care. There is a growing preference for minimally invasive procedures, personalized medicine, and remote patient monitoring. Additionally, there is a rising demand for medical devices that are cost-effective, easy to use, and suitable for the local healthcare infrastructure. Trends in the market indicate a shift towards digital health solutions and telemedicine. With the increasing penetration of smartphones and internet connectivity, there is a growing adoption of mobile health applications and wearable devices. These technologies enable remote patient monitoring, real-time data collection, and improved communication between patients and healthcare providers. Moreover, there is a rising interest in artificial intelligence and machine learning algorithms that can assist in medical diagnosis, treatment planning, and drug discovery. Local special circumstances in Northern Africa contribute to the development of the Medical Technology market. The region faces unique healthcare challenges, including a high burden of infectious diseases, limited healthcare infrastructure, and a shortage of skilled healthcare professionals. These circumstances drive the demand for innovative medical technologies that can address these challenges and improve healthcare access and delivery. Additionally, there is a growing focus on healthcare digitization and the establishment of e-health platforms to overcome geographical barriers and improve healthcare services in remote areas. Underlying macroeconomic factors play a crucial role in the development of the Medical Technology market in Northern Africa. Economic growth, government initiatives, and healthcare investments are key drivers of market expansion. Governments in the region are increasingly investing in healthcare infrastructure, research and development, and medical education to enhance the quality of healthcare services. Furthermore, the rising middle class and increasing disposable income contribute to the affordability and accessibility of medical technologies. However, challenges such as regulatory frameworks, reimbursement policies, and intellectual property rights need to be addressed to foster a favorable business environment for medical technology companies. In conclusion, the Medical Technology market in Northern Africa is experiencing significant growth and development driven by customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The adoption of advanced healthcare solutions, digital health technologies, and telemedicine is transforming the healthcare landscape in the region. However, addressing challenges related to regulations and policies is crucial to sustain the growth of the market and improve healthcare outcomes for the population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.